Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2025-12-25 @ 6:59 PM
NCT ID:
NCT04182204
Group ID:
EG003
Title:
Pola-R-GemOx - Pooled
Description:
All participants who received rituximab, 375 mg/m\^2, IV, followed by polatuzumab vedotin, 1.8 mg/kg, IV on Day 1 of each 21-day cycle either during safety run-in or RCT stage, were included in this arm. Participants also received gemcitabine, 1000 mg/m\^2, IV followed by oxaliplatin 100 mg/m\^2, IV on Day 2 of each 21-day cycle for up to 8 cycles.
Deaths Number Affected:
77
Deaths Number At Risk:
None
Serious Number Affected:
51
Serious Number At Risk:
143
Other Number Affected:
133
Other Number At Risk:
143
Study:
NCT04182204
Results Section:
NCT04182204
Adverse Events Module:
NCT04182204